Editorial Staff

Combatting COVID-19: Life in the MGH Emergency Room

/0 Comments/in , , , , , , /by Editorial Staff
Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Join host Joe Selvaggi and Pioneer Senior Fellow Josh Archambault as they talk with Dr. David King about the experience of being in emergent care during a pandemic and lockdown. They explore the challenges of coping with a poorly understood virus during a lockdown, all while continuing to serve the sick.

Guest:

David R. King, MD, is a trauma and acute care surgeon at the MGH Trauma Center. He is also an attending physician in the Surgical Intensive Care Unit. As a U.S. Army Surgeon, Dr. King has deployed to both Afghanistan and Iraq. He completed running the 2013 Boston Marathon just before the bombings and then worked around the clock in the MGH operating room to help save the lives of victims.

 

 

Get new episodes of Hubwonk in your inbox!

Recent Episodes of Hubwonk:

Diagnosing Debilitating Debt: Are We Undertaxing or Overspending?

Joe Selvaggi talks with Cato Institute’s Director of Tax Policies, Dr. Adam Michell about the sources of recent record levels of deficits and debt to understand a policy path toward fiscal sustainability that is politically viable.

Court Compels Colorblindness: Harvard Told No Exceptions for Equality Under Law

Joe Selvaggi speaks with Thomas A. Berry of Cato Institute about the Supreme Court’s ruling in Students for Fair Admissions Inc. v. President & Fellows of Harvard College, its impact on affirmative action, and what comes next for colleges seeking to ensure diverse enrollments.

Baking Young Minds: Scientific Concerns for Cannabis on Kids

Joe Selvaggi talks with professor of psychiatry Dr. Ryan Sultan about the findings of his recently released study on the effects of cannabis on the mental health of American adolescents. Dr. Sultan’s work shows a substantial correlation between cannabis use and negative mental health outcomes.

Curing Medicaid’s Cold: Unwinding Pandemic Expansion Before Federal Funds End

Joe Selvaggi talks with healthcare policy expert Dr. Brian Blase about Medicaid expansion during the COVID-19 healthcare emergency and how states can efficiently reexamine eligibility criteria so as to protect the vulnerable before federal support expires.

Climate Change Reset: Catastrophic Consensus Cools As New Models Emerge

Joe Selvaggi talks with climate expert Dr. Judith Curry about the insights contained in her newly released book, Climate Uncertainty and Risk: Rethinking our Response, in which she tracks the evolution of climate science from model development, to political weapon, to an emerging view that the best response to a changing climate is to build resiliency.

Dodging Debt Default: Who Won Congressional Cage Match Compromise

Joe Selvaggi talks with CATO Institute budget expert Chris Edwards about the details of the newly passed Fiscal Responsibility Act, which avoids crossing the debt ceiling in exchange for slowing spending growth.

Tilting Offshore Windmills: Speaking Truth to Ratepayers

Joe Selvaggi talks with energy economist Dr. Jonathan Lesser about the chasm between the promises and realities of offshore wind projects, including the likely increased costs passed to electricity consumers and taxpayers.

Picking Patients’ Pockets: Exposing Insurance Schemes Targeting Orphan Diseases

Joe Selvaggi talks with Pioneer Institute’s senior Health Care Fellows Dr. Bill Smith and Dr. Robert Popovian about their white paper "Out-of-Pocket Pirates: Pharmacy Benefit Managers (PBMs) and the Confiscation of Out-of-Pocket Assistance Programs." This episode explores what consumers and regulators can do to ensure those with rare diseases are not left without assistance.

Erec Smith on the Rhetoric of Anti-racist Activism

Joe Selvaggi talks with York College of Pennsylvania Associate Professor Eric Smith about the disempowering effects of modern anti-racism movement and the challenges for thought leaders who espouse more constructive narratives.

Opinion: Drug patents aren’t a ‘necessary evil.’ They save lives.

Drug patents are one of the most important public policy innovations in all of human history, and a boon to patients awaiting cures. Inventions only come when inventors are rewarded, not punished. Patents are not a “necessary evil.”

Study: High List Prices and Deep Discounts for Prescription Drugs Hurt Poor and Sick Patients

A new Pioneer Institute study illustrates how the current system of drug pricing and discounts leads to patients with challenging diseases being charged huge out-of-pocket sums to keep other premiums low, effectively imposing financial penalties on the sick to protect the healthy and wealthy.

Bank of Big Brother: Exploring a National Digital Currency Future

Joe Selvaggi talks with financial privacy and digital currency expert Nicholas Anthony of CATO Institute Center for Monetary and Financial Alternatives about the potential benefits and risks were the U.S. to adopt a national digital currency.